GENVEC, INC.

Address

910 CLOPPER RD STE 220N
GAITHERSBURG, MD, 20878-1353

http://www.genvec.com

Information

DUNS: 806729547
# of Employees: 15

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Adenovirus-vectored RSV vaccine not inhibited by maternal immunity

    Amount: $589,058.00

    DESCRIPTION (provided by applicant): RSV is the leading viral cause of lower respiratory illness and hospitalization in young children, yet there isn't an approved vaccine. The vast majority of c ...

    SBIRPhase I2012Department of Health and Human Services
  2. Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The development of an effective malaria vaccine is a high global health priority. Malaria is the most burdensome parasitic disease of man, exacting an estimated to ...

    SBIRPhase I2012Department of Health and Human Services
  3. Development of an Ad14 Vaccine

    Amount: $500,313.00

    DESCRIPTION (provided by applicant): Recent reports indicate that a new strain of adenovirus serotype 14 (Ad14) is causing frequent acute respiratory disease (ARD) and deaths in otherwise health peopl ...

    SBIRPhase I2009Department of Health and Human Services
  4. Development of Novel Alternative Serotype Adenoviral Vectors for Gene Delivery in

    Amount: $138,699.00

    DESCRIPTION (provided by applicant): Myriad studies have examined the potential of gene therapy in the inner ear. For the most part they have focused on adenoviral vectors and delivery into the cochl ...

    SBIRPhase I2009Department of Health and Human Services
  5. Production of Adenovector Based Vaccines

    Amount: $2,470,960.00

    DESCRIPTION (provided by applicant): Adenovirus vectors (Advectors) designed to express an antigenic gene have shown great promise as vaccines. Although GenVec and other groups have constructed numero ...

    SBIRPhase II2009Department of Health and Human Services
  6. Local Therapy-A Novel Approach to Cancer Metastases

    Amount: $295,991.00

    DESCRIPTION (provided by applicant): Metastases are the leading cause of death of most cancer patients. Leveraging the immune system to eliminate micrometastasis has long been attempted with only mode ...

    SBIRPhase I2009Department of Health and Human Services
  7. High Throughput Genomics Screening for Malaria Antigen Discovery

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Malaria is a major threat to world health. Each year, there are 350-500 million clinical cases and greater than one million deaths due to malaria, primarily of chi ...

    SBIRPhase I2009Department of Health and Human Services
  8. Preclinical Testing of an Adenoviral Vector based HSV-2 Vaccine

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): This proposal will leverage the expertise in HSV-2 and cellular immunology developed at the UW/FHCRC with the state of the art adenovirus delivery platform develop ...

    SBIRPhase I2008Department of Health and Human Services
  9. Adenovirus Vectors for Respiratory Syncytial Virus Vaccination

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the leading viral cause of lower respiratory illness and hospitalization in young children and has long been recognized as a p ...

    SBIRPhase I2008Department of Health and Human Services
  10. Novel Ad5 Malaria Vaccine That Circumvents Pre-existing Ad5 Immunity

    Amount: $599,549.00

    DESCRIPTION (provided by applicant): Malaria is the most devastating parasitic disease affecting humans. Each year, there are 350-500 million clinical cases and greater than one million deaths due t ...

    SBIRPhase I2008Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government